Cadila Healthcare board to consider unaudited financial results

15 Oct 2012 Evaluate
Cadila Healthcare has informed that a meeting of the board of the directors of the company will be held on November 07, 2012, to consider unaudited financial results for the quarter/half-year ended on September 30, 2012 (Q2).

The above information is a part of company's filings submitted to BSE.

Zydus Lifesciences Share Price

977.20 3.30 (0.34%)
23-Dec-2024 12:07 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1823.00
Dr. Reddys Lab 1349.00
Cipla 1480.35
Lupin 2177.60
Zydus Lifesciences 977.20
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.